128 related articles for article (PubMed ID: 34249444)
1. Predicting early recurrence for resected pancreatic ductal adenocarcinoma: a multicenter retrospective study in China.
Liu W; Tang B; Wang F; Qu C; Hu H; Zhuang Y; Gao H; Xie X; Tian X; Yang Y
Am J Cancer Res; 2021; 11(6):3055-3069. PubMed ID: 34249444
[TBL] [Abstract][Full Text] [Related]
2. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma.
Ishido K; Kimura N; Wakiya T; Nagase H; Hara Y; Kanda T; Fujita H; Hakamada K
Ann Surg Oncol; 2022 Feb; 29(2):1281-1293. PubMed ID: 34608555
[TBL] [Abstract][Full Text] [Related]
3. Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma.
Nappo G; Donisi G; Capretti G; Ridolfi C; Pagnanelli M; Nebbia M; Bozzarelli S; Petitti T; Gavazzi F; Zerbi A
Curr Oncol; 2023 Mar; 30(4):3708-3720. PubMed ID: 37185395
[TBL] [Abstract][Full Text] [Related]
4. A novel combined carbohydrate antigen 19-9 and lymphocyte-to-monocyte ratio score can predict early recurrence of resectable pancreatic ductal adenocarcinoma.
Yugawa K; Maeda T; Nagata S; Sakai A; Taketani K; Yamaguchi S; Konishi K; Hashimoto K
Surg Today; 2023 Oct; 53(10):1199-1208. PubMed ID: 36943449
[TBL] [Abstract][Full Text] [Related]
5. A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma.
Shimagaki T; Sugimachi K; Mano Y; Tomino T; Onishi E; Nakashima Y; Sugiyama M; Yamamoto M; Morita M; Shimokawa M; Yoshizumi T; Toh Y
PLoS One; 2023; 18(7):e0288033. PubMed ID: 37450554
[TBL] [Abstract][Full Text] [Related]
6. Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score.
Kim DW; Lee SS; Kim SO; Kim JH; Kim HJ; Byun JH; Yoo C; Kim KP; Song KB; Kim SC
Radiology; 2020 Sep; 296(3):541-551. PubMed ID: 32662759
[TBL] [Abstract][Full Text] [Related]
7. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study.
Zhang XP; Gao YX; Xu S; Zhao GD; Hu MG; Tan XL; Zhao ZM; Liu R
Int J Surg; 2022 Oct; 106():106891. PubMed ID: 36165934
[TBL] [Abstract][Full Text] [Related]
8. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
9. A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics.
Tian N; Wu D; Zhu L; Zeng M; Li J; Wang X
BMC Med Imaging; 2022 Jul; 22(1):116. PubMed ID: 35786426
[TBL] [Abstract][Full Text] [Related]
10. CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time.
Rieser CJ; Zenati M; Hamad A; Al Abbas AI; Bahary N; Zureikat AH; Zeh HJ; Hogg ME
Ann Surg Oncol; 2018 Nov; 25(12):3483-3491. PubMed ID: 29786131
[TBL] [Abstract][Full Text] [Related]
11. Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study.
Zhang XP; Xu S; Gao YX; Zhao ZM; Zhao GD; Hu MG; Tan XL; Lau WY; Liu R
Int J Surg; 2023 Apr; 109(4):785-793. PubMed ID: 36999776
[TBL] [Abstract][Full Text] [Related]
12. Post-adjuvant chemotherapy CA19-9 levels predict prognosis in patients with pancreatic ductal adenocarcinoma: A retrospective cohort study.
Imaoka H; Shimizu Y; Senda Y; Natsume S; Mizuno N; Hara K; Hijioka S; Hieda N; Tajika M; Tanaka T; Ishihara M; Niwa Y; Yamao K
Pancreatology; 2016; 16(4):658-64. PubMed ID: 27178104
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer.
Imamura M; Nagayama M; Kyuno D; Ota S; Murakami T; Kimura A; Yamaguchi H; Kato T; Kimura Y; Takemasa I
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064540
[TBL] [Abstract][Full Text] [Related]
14. Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma.
Wen C; Deng X; Ren D; Song X; Chen H; Wang J; Jin J; Cheng D; Xu Z; Zhang J; Xie J; Qi W; Gu J; Peng C; Chen D; Chen S; Shen B; Zhan Q
Cancer Med; 2020 Oct; 9(20):7626-7636. PubMed ID: 32862515
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma.
Hong S; Song KB; Hwang DW; Lee JH; Lee W; Jun E; Kwon J; Park Y; Park SY; Kim N; Shin D; Kim H; Sung M; Ryu Y; Kim SC
World J Gastrointest Surg; 2021 Nov; 13(11):1423-1435. PubMed ID: 34950431
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma.
Chen T; Zhang MG; Xu HX; Wang WQ; Liu L; Yu XJ
Medicine (Baltimore); 2015 May; 94(19):e751. PubMed ID: 25984661
[TBL] [Abstract][Full Text] [Related]
17. Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Using Preoperative Clinicopathologic Factors.
Kim N; Han IW; Ryu Y; Hwang DW; Heo JS; Choi DW; Shin SH
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935830
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract][Full Text] [Related]
19. Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Zheng Z; Wang X; Huang Y; Lu X; Huang Z; Chi P
Eur J Surg Oncol; 2020 Nov; 46(11):2057-2063. PubMed ID: 32782202
[TBL] [Abstract][Full Text] [Related]
20. A combination of platelet-to-lymphocyte ratio and carbohydrate antigen 19-9 predict early recurrence after resection of pancreatic ductal adenocarcinoma.
Ikuta S; Sonoda T; Aihara T; Yamanaka N
Ann Transl Med; 2019 Sep; 7(18):461. PubMed ID: 31700897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]